Dexlansoprazole
Product Images NDC 70518-3693

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 70518-3693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Dexlansoprazole is a delayed-release capsule of 60mg strength, available in a pack of 30 capsules. It is an RX-only medication with NDC #70518-3692-00 and LOT # information mentioned for reference. Manufactured by Par in Chestnut Ridge, NY, this medication should be kept out of children's reach. The packaging contains FD&C Yellow No. 5, causing allergic reactions in certain individuals susceptible to tartrazine. The directions for use are indicated in the package insert, and it should be stored at 20-25°C (88-77°F); excursions permitted up to 15-30°C (59-86°F).*

FDA Label Image

Structure (Dexlansoprazole Delayed Release Capsules 1)

FDA Label Image

Figure 1 (Dexlansoprazole Delayed Release Capsules 2)

This is a graph depicting the plasma concentration (in ng/mL) of dexlansoprazole at various doses (30mg and 60mg) over time. The x-axis is not available, but the y-axis ranges from 0 to 1200 ng/mL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.